NVO analyst estimates
Novo Nordisk (NVO) analyst ratings, the average price target and its range, and every firm's latest call.
NVO analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Oct 12, 2026 | BMO Capital | Novo Nordisk price target lowered to $40 from $47 at BMO Capital | $40.00 |
| Sep 11, 2026 | Morgan Stanley | Morgan Stanley Downgrades Novo Nordisk (NVO) to Underweight | $40.00 |
| Aug 12, 2026 | Berenberg Bank | Berenberg Downgrades Novo Nordisk (NVO) to Hold | $47.00 |
| Aug 6, 2026 | BMO Capital | Novo Nordisk price target raised to $47 from $45 at BMO Capital | $47.00 |
| Feb 5, 2026 | BMO Capital | Novo Nordisk price target lowered to $45 from $57 at BMO Capital | $45.00 |
| Jan 26, 2026 | BMO Capital | Novo Nordisk (NVO) PT Raised to $57 at BMO Capital | $57.00 |
| Dec 10, 2025 | HSBC | Novo Nordisk price target raised to $54 from $47 at HSBC | $54.00 |
| Dec 3, 2025 | Morgan Stanley | Novo Nordisk price target lowered to $42 from $43 at Morgan Stanley | $42.00 |
| Nov 25, 2025 | BMO Capital | Novo Nordisk (NVO) PT Lowered to $46 at BMO Capital | $46.00 |
| Oct 14, 2025 | BMO Capital | Novo Nordisk price target raised to $55 from $50 at BMO Capital | $55.00 |
| Oct 1, 2025 | HSBC | Novo Nordisk upgraded to Buy from Hold at HSBC | $70.00 |
| Sep 29, 2025 | Morgan Stanley | Novo Nordisk downgraded to Underweight from Equal Weight at Morgan Stanley | $47.00 |
| Jul 31, 2025 | HSBC | Novo Nordisk downgraded to Hold from Buy at HSBC | $57.00 |
| Jul 23, 2025 | Truist Financial | What's Going On With Hims & Hers Stock Wednesday? | $48.00 |
| Oct 17, 2024 | BMO Capital | Novo Nordisk price target lowered to $156 from $160 at BMO Capital | $156.00 |
- 16 firms rate NVO: 8 buy, 8 hold, 0 sell.
- The average price target is $42.33 from 3 analysts, from $40.00 to $47.00.
Updated 2026-11-02 18:26 UTC